RATIONALE FOR COMBINED THERAPY

被引:0
|
作者
FREI, E
机构
[1] SIDNEY FARBER CANC INST,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1002/1097-0142(197707)40:1+<569::AID-CNCR2820400723>3.0.CO;2-D
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:569 / 573
页数:5
相关论文
共 50 条
  • [1] THE RATIONALE AND MANAGEMENT OF COMBINED THERAPY
    LACEY, BW
    BRITISH MEDICAL BULLETIN, 1960, 16 (01) : 42 - 46
  • [2] RATIONALE OF COMBINED MODALITY THERAPY FOR CANCER
    MARTIN, DS
    FUGMANN, R
    STOLFI, R
    HAYWORTH, P
    CANCER CHEMOTHERAPY REPORTS PART 2 SUPPLEMENT, 1974, 4 (01): : 13 - 24
  • [3] RATIONALE FOR COMBINED DRUG-THERAPY IN HYPERTENSION
    LAKE, R
    ZIEGLER, M
    COLEMAN, M
    KOPIN, I
    KIDNEY INTERNATIONAL, 1977, 12 (06) : 502 - 502
  • [4] The mitochondrial cocktail: Rationale for combined nutraceutical therapy in mitochondrial cytopathies
    Tarnopolsky, M. A.
    ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (13-14) : 1561 - 1567
  • [5] Cryoablation and Immunotherapy for Breast Cancer: Overview and Rationale for Combined Therapy
    Regen-Tuero, Helaina C.
    Ward, Robert C.
    Sikov, William M.
    Littrup, Peter J.
    RADIOLOGY-IMAGING CANCER, 2021, 3 (02):
  • [6] Is advanced nasopharyngeal carcinoma a curable disease? The rationale for combined modality therapy
    Dimery, IW
    Glisson, B
    HEAD AND NECK CANCER, VOL 4, 1996, : 578 - 585
  • [7] Rationale for combined antiestrogen-somatostatin analogue therapy of breast cancer
    Pollak, M
    Ingle, J
    Suman, V
    Kugler, J
    ADJUVANT THERAPY OF CANCER VIII, 1997, 8 : 145 - 152
  • [8] Combined cell-gene therapy for lung cancer: rationale, challenges and prospects
    Thakrar, Ricky M.
    Sage, Elizabeth K.
    Janes, Sam M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (07) : 853 - 857
  • [9] Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy
    Vega, GL
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2004, 33 (03) : 525 - +